D. E. Shaw & Co., Inc. Natera, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Natera, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,036,860 shares of NTRA stock, worth $151 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,036,860

Holding current value

$151 Million

% of portfolio

0.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$97.75 - $129.67 $10.6 Million - $14.1 Million	-108,502 Reduced 9.47%	1,036,860 $132 Million
Q2 2024 Aug 14, 2024	BUY	$85.28 - $112.6 $25.9 Million - $34.2 Million	303,905 Added 36.12%	1,145,362 $124 Million
Q1 2024 May 15, 2024	BUY	$59.21 - $92.9 $9.25 Million - $14.5 Million	156,142 Added 22.78%	841,457 $77 Million
Q4 2023 Feb 14, 2024	SELL	$37.55 - $62.64 $1.08 Million - $1.8 Million	-28,664 Reduced 4.01%	685,315 $42.9 Million
Q3 2023 Nov 14, 2023	SELL	$43.4 - $62.52 $16.9 Million - $24.3 Million	-388,368 Reduced 35.23%	713,979 $31.6 Million
Q2 2023 Aug 14, 2023	SELL	$47.08 - $55.16 $17.2 Million - $20.1 Million	-364,629 Reduced 24.86%	1,102,347 $53.6 Million
Q1 2023 May 15, 2023	SELL	$36.57 - $58.29 $2.25 Million - $3.59 Million	-61,590 Reduced 4.03%	1,466,976 $81.4 Million
Q4 2022 Feb 14, 2023	SELL	$34.17 - $47.91 $1.83 Million - $2.56 Million	-53,493 Reduced 3.38%	1,528,566 $61.4 Million
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $7.02 Million - $10.8 Million	-190,008 Reduced 10.72%	1,582,059 $69.3 Million
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $10 Million - $15.9 Million	356,710 Added 25.2%	1,772,067 $62.8 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $38.5 Million - $116 Million	1,271,074 Added 880.96%	1,415,357 $57.6 Million
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $26.2 Million - $36.2 Million	-303,941 Reduced 67.81%	144,283 $13.5 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $35.9 Million - $45.3 Million	-358,348 Reduced 44.43%	448,224 $50 Million
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $19.9 Million - $27.6 Million	-230,797 Reduced 22.25%	806,572 $91.6 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $32.8 Million - $44.7 Million	359,073 Added 52.94%	1,037,369 $105 Million
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $3.13 Million - $5.25 Million	47,025 Added 7.45%	678,296 $67.5 Million
Q3 2020 Nov 16, 2020	BUY	$45.89 - $72.67 $3.22 Million - $5.09 Million	70,088 Added 12.49%	631,271 $45.6 Million
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $9.83 Million - $18.6 Million	372,838 Added 197.95%	561,183 $28 Million
Q1 2020 May 15, 2020	BUY	$17.27 - $40.17 $3.25 Million - $7.57 Million	188,345 New	188,345 $5.62 Million
Q3 2019 Nov 14, 2019	SELL	$25.38 - $34.89 $820,002 - $1.13 Million	-32,309 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$17.75 - $27.58 $2.44 Million - $3.8 Million	-137,729 Reduced 81.0%	32,309 $891,000
Q1 2019 May 15, 2019	BUY	$11.34 - $20.62 $624,675 - $1.14 Million	55,086 Added 47.92%	170,038 $3.51 Million
Q4 2018 Feb 14, 2019	SELL	$12.32 - $24.38 $637,338 - $1.26 Million	-51,732 Reduced 31.04%	114,952 $1.61 Million
Q3 2018 Nov 14, 2018	SELL	$18.82 - $28.96 $704,413 - $1.08 Million	-37,429 Reduced 18.34%	166,684 $3.99 Million
Q2 2018 Aug 14, 2018	SELL	$8.79 - $19.98 $983,038 - $2.23 Million	-111,836 Reduced 35.4%	204,113 $3.84 Million
Q1 2018 May 15, 2018	SELL	$9.0 - $11.95 $113,040 - $150,092	-12,560 Reduced 3.82%	315,949 $2.93 Million
Q4 2017 Feb 14, 2018	BUY	$8.99 - $14.31 $484,956 - $771,938	53,944 Added 19.65%	328,509 $2.95 Million
Q3 2017 Nov 14, 2017	BUY	$8.02 - $13.33 $2.2 Million - $3.66 Million	274,565	274,565 $3.54 Million

Others Institutions Holding NTRA

# of Institutions

526

Shares Held

119M

Call Options Held

308K

Put Options Held

191K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $14.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account